NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 133 filers reported holding NEKTAR THERAPEUTICS in Q2 2024. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 1,334,661 | $3,016,334 | 2.93% |
| CM Management, LLC | 125,000 | $283 | 0.34% |
| Birchview Capital, LP | 118,000 | $267 | 0.19% |
| Acrisure Capital Management, LLC | 72,131 | $163,016 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 645,035 | $1,458 | 0.18% |
| Edgestream Partners, L.P. | 608,851 | $1,376,003 | 0.16% |
| Virtus ETF Advisers LLC | 110,420 | $249,549 | 0.13% |
| Rhenman & Partners Asset Management AB | 550,000 | $1,243,000 | 0.13% |
| iSAM Funds (UK) Ltd | 14,780 | $33,403 | 0.10% |
| PDT Partners, LLC | 252,688 | $571,075 | 0.09% |